CAESAREA, Israel--(BUSINESS WIRE)--Mazor Robotics Ltd. (TASE: MZOR), a developer of innovative surgical robots and complementary products, today announced that Reston Hospital Center, a HCA Virginia health system hospital, purchased its Renaissance™ system. Renaissance is Mazor’s next-generation robotic surgical guidance system used for spine surgeries.
Reston Hospital Center is a full service medical and surgical hospital that has served the residents of Northern Virginia since 1986. HCA, Inc. is the nation’s leading provider of healthcare services with 157 hospitals and more than 100 freestanding surgery centers in 20 states and London, England.
"Introducing robotic technology will help differentiate our facility as a leading provider of state-of-the- art spine surgery," commented Dhruv B. Pateder, MD, a dual trained neurosurgical and orthopedic spine surgeon. As a leader in minimally invasive spinal surgery, Dr. Pateder also stated "the level of accuracy provided by the Mazor robotic system is revolutionary in terms of allowing further improvements to current minimally invasive techniques and further improving patient safety, recovery and outcomes."
“We are thrilled to provide Reston Hospital Center with our Renaissance System platform, the first system installed in Virginia,” stated Ori Hadomi, chief executive officer of Mazor Robotics. “Reston Hospital Center and the local geographic region are known for adopting innovative technologies that improve patient care. We are proud that this marks our first installation in the prestigious HCA healthcare network.”
About Mazor
Mazor Robotics (TASE:MZOR) is dedicated to the development and marketing of innovative surgical robots and complementary products that provide a safer surgical environment for patients, surgeons, and operating room staff. Mazor Robotics’ flagship product, Renaissance™, is a state-of-the-art surgical robotic system that enables surgeons to conduct spine surgeries in an accurate and secure manner. Mazor Robotics systems have been successfully used in the placement of over 20,000 implants in the United States and Europe. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics technology. For more information, please visit www.mazorrobotics.com.